Revolutionizing Drug Discovery with the New ECHO655 System

Breaking New Ground in High-Throughput Synthesis!

We are thrilled to announce a major milestone in our research capabilities—the arrival of the cutting-edge ECHO655 instrument! This latest addition to our laboratory marks a significant leap forward in nanoscale high-throughput synthesis (HTS), reinforcing our position as a global leader in miniaturized and automated drug discovery.

Expanding Our Technological Arsenal

With the powerful ECHO655 now complementing our trusted ECHO555, we have established one of the most advanced synthetic ECHO systems in the world. This state-of-the-art technology, supported by the ERC Advanced Grant AMADEUS, enables us to:

  • Synthesize tens of thousands of novel small molecules per day
  • Screen hundreds of “drug-like” scaffolds with unparalleled efficiency
  • Seamlessly integrate HTS analytics and purification workflows using multiple UPLC-MS-UV-(CAD) and autopurifiers
  • Perform semi-automated building block synthesis on a multi-mg to gram scale via the TECAN-EVO system
  • Accelerate data generation for AI and machine learning to revolutionize predictive modeling in drug discovery

Driving Innovation in Drug Development

This breakthrough in nanoscale synthesis paves the way for transformative research in:

  • Cancer therapeutics
  • Anti-infective drug development
  • Metabolic disease treatments

By leveraging cutting-edge HTS instrumentation, including cell painting assays, ECHO-MS, and AI-driven analytics, we are redefining the future of drug discovery. Our mission is to accelerate the path from concept to cure, delivering next-generation solutions to global health challenges.

Join Us at Upcoming Conferences!

We are excited to share our latest advancements at two key scientific gatherings:

ACS Spring Meeting – San Diego, 2025
1st ICIQ High-Throughput Experimentation Symposium
“Accelerating Synthetic Development: HTE, AI/ML, and the Future of Autonomous Labs”
🔗 Learn more here

Let’s Collaborate!

Are you interested in exploring collaboration opportunities or learning more about our cutting-edge capabilities? Let’s connect and drive the future of therapeutic innovation together!